We are live on
!
Find out more
DI
DKRT Investments Portfolio holdings
AUM
$409M
1-Year Est. Return
14.44%
This Fund
S&P 500
This Quarter
Est. Return
+1.14%
1 Year Est. Return
-14.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$409M
AUM Growth
+$14.7M
(+3.7%)
Cap. Flow
+$17.4M
Cap. Flow
% of AUM
4.25%
Top 10 Holdings %
Top 10 Hldgs %
71.46%
Holding
53
New
5
Increased
3
Reduced
3
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$18.7M |
| 2 |
Alcon
ALC
|
+$13.2M |
| 3 |
Stryker
SYK
|
+$13.1M |
| 4 |
Allegion
ALLE
|
+$9.92M |
| 5 |
FDXF
FedEx Freight
FDXF
|
+$7.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$27.8M |
| 2 |
Canadian National Railway
CNI
|
+$6.03M |
| 3 |
Icon
ICLR
|
+$5.53M |
| 4 |
Goldman Sachs
GS
|
+$4.87M |
| 5 |
Caterpillar
CAT
|
+$4.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 40.41% |
| 2 | Healthcare | 28.3% |
| 3 | Financials | 24.73% |
| 4 | Consumer Discretionary | 3.07% |
| 5 | Consumer Staples | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nutrien
NTR
$34.9B
| $2.83M | 0.69% |
45,000
| – | – |
|
27
Nike
NKE
$59.7B
| $2.26M | 0.55% |
55,000
| – | – |
|
28
Telus
TU
$15.8B
| $2.11M | 0.52% |
200,000
| – | – |
|
29
Shake Shack
SHAK
$2.98B
| $1.96M | 0.48% |
35,000
+10,000
| +40% | +$753K |
|
30
Walt Disney
DIS
$185B
| $1.93M | 0.47% |
20,000
| – | – |
|
31
Citigroup
C
$218B
| $1.89M | 0.46% |
13,500
| – | – |
|
32
GE Aerospace
GE
$358B
| $1.87M | 0.46% |
5,000
| – | – |
|
33
GE Vernova
GEV
$257B
| $1.47M | 0.36% |
1,250
| – | – |
|
34
ExxonMobil
XOM
$683B
| $1.37M | 0.33% |
10,000
| – | – |
|
35
Walmart Inc
WMT
$826B
| $1.13M | 0.28% |
10,000
| – | – |
|
36
Algonquin Power & Utilities
AQN
$4.48B
| $1.03M | 0.25% |
175,000
| – | – |
|
37
TPG
TPG
$19.8B
| $1.01M | 0.25% |
25,000
| – | – |
|
|
SPCX
38
SpaceX
SPCX
$1.77T
| $854K | 0.21% |
+5,000
| New | +$849K |
|
39
Pfizer
PFE
$158B
| $843K | 0.21% |
35,000
| – | – |
|
40
RELX
RELX
$61.7B
| $792K | 0.19% |
25,000
| – | – |
|
41
Biogen
BIIB
$31.7B
| $540K | 0.13% |
2,500
| – | – |
|
42
Solventum
SOLV
$15.1B
| $482K | 0.12% |
6,250
| – | – |
|
43
Vertex
VERX
$2.2B
| $344K | 0.08% |
30,000
| – | – |
|
44
Nu Holdings
NU
$68.6B
| $334K | 0.08% |
25,000
| – | – |
|
45
Ovintiv
OVV
$18.4B
| $158K | 0.04% |
3,000
| – | – |
|
46
BCE
BCE
$22.2B
| $138K | 0.03% |
6,400
| – | – |
|
47
GE HealthCare
GEHC
$33.5B
| $107K | 0.03% |
1,666
| – | – |
|
48
Viatris
VTRS
$18.5B
| $68.9K | 0.02% |
4,341
| – | – |
|
49
Wabtec
WAB
$49.4B
| $57.7K | 0.01% |
214
| – | – |
|
50
Organon & Co
OGN
$3.61B
| $16.9K | ﹤0.01% |
1,250
| – | – |
|
Similar funds
IFS
APWM
RPA
HWM
PFG
RWA
SWA
SA
DKRT Investments's Q2 2026 Portfolio in Review
As of Q2 2026, DKRT Investments held 53 positions worth $409M, up 3.7% from $395M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
DKRT Investments deployed $17.4M of net new capital in Q2 2026, opening 5 new positions and adding to 3 existing holdings. Its largest new stake was Alcon: 188,500 shares worth $12.6M.
By sector, the portfolio is most concentrated in Industrials at 40% of assets, down from 41% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $4.87M trimmed.
- DKRT Investments's largest Q2 2026 buy was Alcon: 188,500 shares worth $12.6M.
- DKRT Investments added most to Boston Scientific in Q2 2026, an estimated $18.7M increase.
- DKRT Investments's biggest Q2 2026 reduction was Goldman Sachs, cutting an estimated $4.87M.
- DKRT Investments fully exited Elevance Health in Q2 2026, selling an estimated $27.8M.
- DKRT Investments's ten largest holdings make up 71% of its $409M portfolio in Q2 2026.
- DKRT Investments opened 5 new positions and closed 3 in Q2 2026.
- DKRT Investments's portfolio value rose 3.7% quarter-over-quarter to $409M.
Based on DKRT Investments's 13F filing for Q2 2026, filed 13 Aug 2026.